Cas:1159976-38-1 Ethyl 6-bromo-4-chloroquinazoline-2-carboxylate manufacturer & supplier

Chemical Name:Ethyl 6-bromo-4-chloroquinazoline-2-carboxylate

CAS.NO:1159976-38-1

Synonyms:Ethyl 6-bromo-4-chloroquinazoline-2-carboxylate

Molecular Formula:C₁₁H₈BrClN₂O₂

Molecular Weight:315.55000

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:440.4ºC at 760 mmHg

Density:1.638 g/cm3

Index of Refraction:

PSA:52.08000

Exact Mass:313.94600

LogP:3.22240

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Ethyl 6-bromo-4-chloroquinazoline-2-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl 6-bromo-4-chloroquinazoline-2-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl 6-bromo-4-chloroquinazoline-2-carboxylate Use and application,Ethyl 6-bromo-4-chloroquinazoline-2-carboxylate technical grade,usp/ep/jp grade.

Related News: As the global generic drug market booms and the international API industry accelerates its transfer to developing countries, China and India rely on cost advantages to rapidly grow into major API producers and exporters. Ethyl 6-bromo-4-chloroquinazoline-2-carboxylate manufacturer In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market. Ethyl 6-bromo-4-chloroquinazoline-2-carboxylate supplier Catalent��s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management. Ethyl 6-bromo-4-chloroquinazoline-2-carboxylate vendor Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement. Ethyl 6-bromo-4-chloroquinazoline-2-carboxylate factory Catalent��s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.